Get the Stockscreener App
0.00
100.00%
-179.95
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$179.95
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.42B
Revenue:
$1.56B
Net Income/Loss:
$216.80M
P/E Ratio:
0.00
EPS:
1.458
Net Cash Flow:
$206.10M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$179.99
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
0.00 | 9.42B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
90.53 | 157.69B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
310.00 | 118.84B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.63 | 103.21B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.60 | 67.78B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.95 | 50.07B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Danaher achieves FDA clearance for Masimo feature, shares steady on NYSE - AD HOC NEWS
Deals tracker: Hackensack Meridian Health explores merger - Modern Healthcare
The Radius VSM from Masimo Corp.FDA-cleared opioid risk alerts on the wrist - AD HOC NEWS
California Forum Selection Clause Enforced in Lawsuit - The National Law Review
Danaher Finalizes $9.9B Purchase of Masimo - Orange County Business Journal
Masimo wins FDA clearance for wearable opioid-risk monitor - Stock Titan
Medtech business update: Spectrum Vascular acquires Piccolo Medical, Danaher acquires Masimo - Today's Medical Developments
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple - Stocktwits
Danaher boosts product portfolio with the acquisition of Masimo - MSN
SIRI stock surges 5% after-hours on S&P MidCap 400 inclusion - MSN
ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review - Law360
Masimo Corp (MASI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Masimo Corp (MASI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Masimo Corp (MASI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Masimo Corp (MASI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Katie Szyman Steps Down from Masimo - Orange County Business Journal
Masimo CEO stepping down following acquisition by Danaher - Modern Healthcare
Silent monitoring boost, Masimo Stork smart baby monitor targets anxious new parents - AD HOC NEWS
Masimo Corp. (Sound United): Denon AVR-X3800H stays a flexible 9.4-channel AV receiver - AD HOC NEWS
Danaher completes acquisition of Masimo, company delists from Nasdaq By Investing.com - Investing.com Nigeria
Danaher Deepens Diagnostics Reach As Masimo Deal Reshapes Healthcare Focus - Yahoo Finance
Masimo (MASI) director’s shares and RSUs cashed out at $180 in Danaher merger - Stock Titan
Masimo (MASI) director’s shares and RSUs cashed out in Danaher merger - Stock Titan
Masimo (MASI) director equity cashed out at $180 per share in Danaher merger - Stock Titan
[Form 4] MASIMO CORP Insider Trading Activity - Stock Titan
Politan Capital and Quentin Koffey cash out Masimo (MASI) at $180 per share - Stock Titan
Masimo (MASI) executive reports stock and RSU disposition in Danaher merger - Stock Titan
Masimo (MASI) EVP equity cashed out and converted in Danaher merger - Stock Titan
Masimo (MASI) CCO reports merger-driven cancellation and conversion of equity awards - Stock Titan
Masimo (MASI) CHRO equity canceled, cashed out and rolled into Danaher - Stock Titan
Masimo (MASI) GC reports RSU disposals as Danaher merger converts awards - Stock Titan
Masimo (MASI) CMO disposes RSUs, options as Danaher merger closes - Stock Titan
Masimo (MASI) CFO exits company stock as Danaher cash merger closes - Stock Titan
Masimo (MASI) CEO awards canceled, paid $180 per share in Danaher deal - Stock Titan
Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView
MASI Should I Buy - Intellectia AI
Masimo (MASI) bought out for $180 per share as Politan exits stake - Stock Titan
Danaher completes $10B acquisition of Masimo - MassDevice
Danaher Closes on Acquisition of Masimo - Orange County Business Journal
Masimo (MASI) removes unsold S-3 securities after Danaher merger - Stock Titan
Danaher completes acquisition of Masimo, company delists from Nasdaq - Investing.com UK
Masimo Pays Off and Terminates 2025 Credit Agreement as Danaher Merger Closes - TradingView
Danaher acquires Masimo (MASI) in all-cash $180-per-share takeover and delisting - Stock Titan
Masimo Corp (NASDAQ: MASI) common stock removed from Nasdaq listing - Stock Titan
Danaher completes acquisition of Masimo Corporation - Investing.com
Danaher completes acquisition of Masimo Corporation By Investing.com - Investing.com Canada
Danaher Completes Acquisition of Masimo Corporation - Yahoo Finance
Masimo Received Notice of Delisting - TradingView
MASI News | MASIMO CORP (NASDAQ:MASI) - ChartMill
Why is Sirius XM stock rallying today? By Investing.com - Investing.com India
Masimo Corporation stock hits 52-week high at 179.98 USD By Investing.com - Investing.com India
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
1.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):